{"id":"sennosides","rwe":[],"_fda":{"id":"45b0b98b-033f-9ada-e063-6294a90ab6e4","set_id":"05a54614-a6ad-4861-87b8-9e2ee49bad20","openfda":{"upc":["0357896472085"],"unii":["3FYP5M0IJX"],"route":["ORAL"],"rxcui":["702311"],"spl_id":["45b0b98b-033f-9ada-e063-6294a90ab6e4"],"brand_name":["GeriCare Senna Syrup"],"spl_set_id":["05a54614-a6ad-4861-87b8-9e2ee49bad20"],"package_ndc":["57896-472-08"],"product_ndc":["57896-472"],"generic_name":["SENNOSIDES"],"product_type":["HUMAN OTC DRUG"],"substance_name":["SENNOSIDES"],"manufacturer_name":["Geri-Care Pharmaceutical Corp."],"application_number":["M007"],"is_original_packager":[true]},"purpose":["Laxative"],"version":"4","warnings":["Do not use laxative products for longer than 1 week unless directed by a doctor. Ask a doctor or pharmacis before use if you have stomach pain, nausea or vomiting noticed a change in bowel habits that lasts over two weeks. Stop use and ask a doctor if you have rectal bleeding or failure to have a bowel movement after use of a laxative. These may indicate a serious condition."],"pregnancy":["If pregnant or breast-feeding, ask a health professional before use."],"questions":["Questions or comments? 1-800-540-3765"],"effective_time":"20251211","active_ingredient":["Active ingredient (in each 5 ml teaspoonful): Sennosides 8.8 mg"],"inactive_ingredient":["Inactive ingredients: Artificial and natural chocolate flavor, methylparaben, propylene glycol, propylparaben, purified water, and sucrose."],"storage_and_handling":["Store at room temperature 15 o - 25 o C (59 o - 77 o F) TAMPER-EVIDENT: Do not use if foil seal over bottle opening is torn, broken, or missing."],"indications_and_usage":["relieves occasional constipation (irregularity) generally causes bowel movement in 6 to 12 hours"],"dosage_and_administration":["Shake well before using Do not exceed recommended dose Age Starting Dose Maximum Dose adults and children 12 years and older 2-3 teaspoonfuls once a day preferably at bedtime; increase as needed or as recommended by a doctor 3 teaspoons in the morning and 3 teaspoons at bedtime Under 12 years of age ask a doctor ask a doctor"],"spl_product_data_elements":["GeriCare Senna Syrup Sennosides METHYLPARABEN PROPYLENE GLYCOL PROPYLPARABEN WATER SUCROSE SENNOSIDES SENNOSIDES"],"keep_out_of_reach_of_children":["Keep out of reach of children. In case of accidental overdose, get medical help or contact a Poison Control Center immediately."],"dosage_and_administration_table":["<table width=\"100%\"><caption/><tbody><tr><td> Age</td><td> Starting Dose</td><td> Maximum Dose</td></tr><tr><td>adults and children 12 years and older</td><td> 2-3 teaspoonfuls once a day preferably at bedtime; increase as needed or as recommended by a doctor</td><td>3 teaspoons in the morning and 3 teaspoons at bedtime</td></tr><tr><td>Under 12 years of age</td><td> ask a doctor</td><td> ask a doctor</td></tr></tbody></table>"],"package_label_principal_display_panel":["NDC 57896-472-08 Geri Care Senna Syrup Natural Vegetable Laxative 8 fl oz (237 mL) Code# L-002 REV0524 PDP SS"]},"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Oral","category":"route"},{"label":"Bar","category":"form"},{"label":"Capsule","category":"form"},{"label":"Extract","category":"form"},{"label":"Liquid","category":"form"},{"label":"Active","category":"status"},{"label":"Constipation","category":"indication"},{"label":"Gastrointestinal Agents","category":"pharmacology"},{"label":"Laxatives","category":"pharmacology"}],"phase":"marketed","safety":{"boxedWarnings":[],"safetySignals":[{"date":"","signal":"FATIGUE","source":"FDA FAERS","actionTaken":"5236 reports"},{"date":"","signal":"NAUSEA","source":"FDA FAERS","actionTaken":"4830 reports"},{"date":"","signal":"CONSTIPATION","source":"FDA FAERS","actionTaken":"4113 reports"},{"date":"","signal":"DYSPNOEA","source":"FDA FAERS","actionTaken":"3847 reports"},{"date":"","signal":"DIARRHOEA","source":"FDA FAERS","actionTaken":"3722 reports"},{"date":"","signal":"DEATH","source":"FDA FAERS","actionTaken":"3525 reports"},{"date":"","signal":"PAIN","source":"FDA FAERS","actionTaken":"3451 reports"},{"date":"","signal":"FALL","source":"FDA FAERS","actionTaken":"3034 reports"},{"date":"","signal":"VOMITING","source":"FDA FAERS","actionTaken":"3015 reports"},{"date":"","signal":"PNEUMONIA","source":"FDA FAERS","actionTaken":"3003 reports"}],"commonSideEffects":[],"contraindications":["Appendicitis","Gastrointestinal obstruction","Incontinence of feces","Intestinal Impaction","Intestinal obstruction"],"specialPopulations":{"Pregnancy":"If pregnant or breast-feeding, ask healthcare professional before use."}},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=SENNOSIDES","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:08:20.469660+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:08:31.966380+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=SENNOSIDES","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:08:32.811391+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:08:18.242005+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:08:18.242059+00:00"},"safety.safetySignals":{"url":"https://api.fda.gov/drug/event.json","method":"api_direct","source":"FDA FAERS","rawText":"","confidence":1,"sourceType":"fda_faers","retrievedAt":"2026-04-20T01:08:34.336227+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108559/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:08:33.281144+00:00"},"regulatory.fda_application":{"url":"","method":"deterministic","source":"FDA Label","rawText":"M007","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:08:18.242070+00:00"}},"allNames":["sennosides a&b","sennosides a and b","sennosides"],"offLabel":[],"synonyms":["sennosides a&b","sennosides a and b","sennosides"],"timeline":[],"approvals":[{"date":"","orphan":false,"company":"","regulator":"FDA"}],"ecosystem":[{"indication":"Constipation","otherDrugs":[{"name":"bisacodyl","slug":"bisacodyl","company":"Braintree"},{"name":"cholic acid","slug":"cholic-acid","company":"Rtrx"},{"name":"docusate sodium","slug":"docusate-sodium","company":""},{"name":"glycerol","slug":"glycerol","company":"B Braun"}],"globalPrevalence":1120000000}],"mechanism":{"modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"Sennosides act as anthraquinone laxatives, which increase the amount of water in the intestines and stimulate the muscles to contract, thereby promoting the movement of stool through the digestive system."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4307","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=SENNOSIDES","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=SENNOSIDES","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:36:54.386374","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:08:36.299245+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"sennosides","indications":{"approved":[{"name":"Constipation","source":"DrugCentral","snomedId":14760008,"regulator":"FDA","eligibility":"Adults and children 6 years of age and older","usPrevalence":null,"globalPrevalence":1120000000,"prevalenceMethod":"curated","prevalenceSource":"Am J Gastroenterol, 2011 (PMID:21606976)"}],"offLabel":[{"name":"Incomplete passage of stool","source":"DrugCentral","drugName":"SENNOSIDES"},{"name":"Irritable bowel syndrome","source":"DrugCentral","drugName":"SENNOSIDES"}],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT04930237","phase":"","title":"RELISTOR's Effects on Opioid-Induced Constipation","status":"WITHDRAWN","sponsor":"Methodist Health System","startDate":"2021-07-01","conditions":["OIC"],"enrollment":0,"completionDate":"2022-04-22"},{"nctId":"NCT06335797","phase":"NA","title":"Optimization of Postoperative Bowel Habits","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2024-10-16","conditions":["Constipation"],"enrollment":88,"completionDate":"2027-05"},{"nctId":"NCT07426133","phase":"NA","title":"Whatsapp Based Patient Education to Improve Bowel Preparation for Colonoscopy","status":"COMPLETED","sponsor":"Shaukat Khanum Memorial Cancer Hospital & Research Centre","startDate":"2025-03-23","conditions":["Assessing Bowel Preparation Quality"],"enrollment":110,"completionDate":"2025-12-26"},{"nctId":"NCT07229066","phase":"NA","title":"The Effect of Video-Based Education on Colonoscopy Preparation","status":"RECRUITING","sponsor":"Eskisehir Osmangazi University","startDate":"2024-06-01","conditions":["Bowel Preparation Quality","Colonoscopy","Patient Education"],"enrollment":246,"completionDate":"2026-03-30"},{"nctId":"NCT07215351","phase":"NA","title":"Impact of the Inno Cleanse Dietary Supplement on Gut Health and Associated Variables in Healthy Men and Women","status":"RECRUITING","sponsor":"University of Memphis","startDate":"2025-10-07","conditions":["Constipation","Bloating"],"enrollment":30,"completionDate":"2026-01-01"},{"nctId":"NCT00001337","phase":"PHASE2","title":"Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"1993-05-08","conditions":["Diffuse Large B-Cell Lymphoma (DLBCL)","Primary Mediastinal Large B-cell Lymphoma","Burkitt Lymphoma","Anaplastic Large-Cell Lymphoma","Gray Zone Lymphoma"],"enrollment":348,"completionDate":"2024-05-24"},{"nctId":"NCT06825260","phase":"PHASE4","title":"PEG3350 vs Senna After Urogyn Surgery","status":"RECRUITING","sponsor":"St. Joseph's Health, New York","startDate":"2025-04-23","conditions":["Obstructive Defecation Syndrome","Postoperative Constipation"],"enrollment":254,"completionDate":"2027-07"},{"nctId":"NCT03342157","phase":"PHASE2","title":"Docusate/Senna for the Treatment of Diabetic Gastroparesis","status":"TERMINATED","sponsor":"Wake Forest University Health Sciences","startDate":"2018-04-02","conditions":["Diabetic Gastroparesis"],"enrollment":2,"completionDate":"2018-08-17"},{"nctId":"NCT06580366","phase":"PHASE4","title":"Comparing Sennosid A+B and Sodium Picosulfate/Magnesium Oxide/Citric Acid for Bowel Preparation","status":"NOT_YET_RECRUITING","sponsor":"Hitit University","startDate":"2024-08-22","conditions":["Bowel Preparation"],"enrollment":600,"completionDate":"2025-03-22"},{"nctId":"NCT03148002","phase":"PHASE4","title":"Peritoneal Dialysis Pilot Study: Evaluating Polyethylene Glycol (PEG) for Constipation","status":"COMPLETED","sponsor":"Nova Scotia Health Authority","startDate":"2017-07-07","conditions":["Constipation","Peritoneal Dialysis Complication"],"enrollment":25,"completionDate":"2018-06-05"},{"nctId":"NCT06561035","phase":"PHASE3","title":"ACL-R Opioid Sparing Study","status":"ENROLLING_BY_INVITATION","sponsor":"Campbell Clinic","startDate":"2024-09-01","conditions":["Anterior Cruciate Ligament Injuries"],"enrollment":56,"completionDate":"2026-06"},{"nctId":"NCT06021639","phase":"NA","title":"Comparison of Bowel Cleansing Regimens for Colonoscopy","status":"COMPLETED","sponsor":"Mersin University","startDate":"2023-11-20","conditions":["Colonoscopy Preparation"],"enrollment":144,"completionDate":"2024-02-18"},{"nctId":"NCT03491540","phase":"PHASE3","title":"Mechanical Bowel Preparation and Oral Antibiotics Before Rectal Cancer Surgery","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2018-09-03","conditions":["Rectal Cancer Surgery"],"enrollment":414,"completionDate":"2023-12-12"},{"nctId":"NCT05862519","phase":"NA","title":"A Clinical Study to Evaluate the Efficacy of Four Supplements on Improving Readiness for Intimacy","status":"UNKNOWN","sponsor":"906 CMVI Holdings","startDate":"2023-03-14","conditions":["Libido","Intimacy","Gastrointestinal Issues"],"enrollment":36,"completionDate":"2023-06-13"},{"nctId":"NCT05862532","phase":"EARLY_PHASE1","title":"Gut Microbiome and Blood Markers After Habitual Herbal Tea Consumption","status":"UNKNOWN","sponsor":"Aberystwyth University","startDate":"2022-11-17","conditions":["Obesity","Well-being"],"enrollment":55,"completionDate":"2023-05-31"},{"nctId":"NCT02977286","phase":"PHASE4","title":"Naloxegol to Prevent Lower Gastrointestinal Paralysis in Critically Ill Adults Administered Opioids","status":"TERMINATED","sponsor":"Tufts Medical Center","startDate":"2017-01-01","conditions":["Constipation"],"enrollment":12,"completionDate":"2019-10-09"},{"nctId":"NCT03501498","phase":"NA","title":"Gut Transit Effect on Enterohepatic Circulation","status":"COMPLETED","sponsor":"University Hospital Plymouth NHS Trust","startDate":"2017-04-10","conditions":["Intestinal Transit"],"enrollment":19,"completionDate":"2022-03-01"},{"nctId":"NCT03475680","phase":"PHASE3","title":"Mechanical Bowel Preparation and Oral Antibiotics Before Colon Cancer Surgery","status":"TERMINATED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2018-08-08","conditions":["Colon Cancer"],"enrollment":193,"completionDate":"2022-03-23"},{"nctId":"NCT03593252","phase":"NA","title":"Bowel Preparation in Elective Pediatric Colorectal Surgery","status":"UNKNOWN","sponsor":"McMaster University","startDate":"2022-01-01","conditions":["Colostomy","Hirschsprung Disease - Pull Through","Necrotizing Enterocolitis","Inflammatory Bowel Diseases","Meconium Ileus","Bowel Obstruction","Elective Surgery"],"enrollment":81,"completionDate":"2024-01-30"},{"nctId":"NCT01695850","phase":"PHASE2","title":"A Double-blinded,Double-dummy Clinical Trial of Chinese Herbal Medicine (MaZiRenWan) for Functional Constipation","status":"COMPLETED","sponsor":"Hong Kong Baptist University","startDate":"2013-06","conditions":["Functional Constipation","Gastrointestinal Disorders"],"enrollment":291,"completionDate":"2015-08"},{"nctId":"NCT04273295","phase":"NA","title":"Massage With Senna-based Laxatives Versus Senna-based Laxatives in Managing Overflow Retentive Stool Incontinence","status":"COMPLETED","sponsor":"South Valley University","startDate":"2019-04-01","conditions":["Massage"],"enrollment":50,"completionDate":"2019-10-15"},{"nctId":"NCT02720822","phase":"PHASE3","title":"Breathlessness Exertion and Morphine Sulphate","status":"COMPLETED","sponsor":"Flinders University","startDate":"2016-08-08","conditions":["Chronic Obstructive Pulmonary Disease","Dyspnea"],"enrollment":171,"completionDate":"2019-12-20"},{"nctId":"NCT04102566","phase":"PHASE4","title":"Optimizing Pain Control in Transurethral Resection of the Prostate","status":"RECRUITING","sponsor":"Benaroya Research Institute","startDate":"2017-12-08","conditions":["Pain","BPH With Urinary Obstruction","BPH With Urinary Obstruction With Other Lower Urinary Tract Symptoms"],"enrollment":50,"completionDate":"2019-12-01"},{"nctId":"NCT01189409","phase":"PHASE4","title":"Polyethylene Glycol (PEG) Versus Sennosides Study in Opioid-Induced Constipation in Cancer Patients","status":"TERMINATED","sponsor":"British Columbia Cancer Agency","startDate":"2010-06","conditions":["Constipation","Cancer"],"enrollment":70,"completionDate":"2018-10"},{"nctId":"NCT01575093","phase":"PHASE1,PHASE2","title":"Safety Evaluation of Bowel Cleansing Regimen for PillCam® COLON 2 Capsule Endoscopy","status":"COMPLETED","sponsor":"Medtronic - MITG","startDate":"2012-03","conditions":["Healthy Volunteers"],"enrollment":25,"completionDate":"2012-06"},{"nctId":"NCT02239510","phase":"NA","title":"Efficacy of Linaclotide to Senna for CIC","status":"TERMINATED","sponsor":"TriHealth Inc.","startDate":"2014-09","conditions":["Chronic Idiopathic Constipation"],"enrollment":9,"completionDate":"2016-06"},{"nctId":"NCT03745183","phase":"NA","title":"Senna Alata Leaf Decoction as a Treatment for Tinea Imbricata","status":"COMPLETED","sponsor":"Philippine Dermatological Society","startDate":"2014-11","conditions":["Tinea Imbricata"],"enrollment":20,"completionDate":"2015-01-15"},{"nctId":"NCT02383758","phase":"NA","title":"An Interdisciplinary Approach to the Treatment of Encopresis in Children With Autism Spectrum Disorders","status":"COMPLETED","sponsor":"Emory University","startDate":"2015-02-01","conditions":["Encopresis","Autistic Disorder"],"enrollment":22,"completionDate":"2017-01-01"},{"nctId":"NCT02618564","phase":"NA","title":"The Use of Sennosides With Pico Salax in Bowel Preparation for Colonoscopy: a Study of Optimal Dose and Timing","status":"COMPLETED","sponsor":"Queen's University","startDate":"2016-01","conditions":["Colonoscopy Preparation Outcome"],"enrollment":100,"completionDate":"2017-08"},{"nctId":"NCT02481219","phase":"NA","title":"Optimization of the Bowel Preparation Regimen for the PillCam® COLON 2 Capsule Endoscopy Procedure","status":"COMPLETED","sponsor":"Medtronic - MITG","startDate":"2015-05","conditions":["Colorectal Cancer Screening"],"enrollment":122,"completionDate":"2016-02"},{"nctId":"NCT02665624","phase":"PHASE4","title":"Adding Stewed Apricot Juice to Senna Improves the Right-Side and Overall Colon Cleansing Quality for Colonoscopy Preparation","status":"COMPLETED","sponsor":"Camlıca Erdem Hospital","startDate":"2015-04","conditions":["Colonoscopy Preparation"],"enrollment":128,"completionDate":"2015-06"},{"nctId":"NCT00799201","phase":"PHASE4","title":"Enteral Naloxone Versus a Traditional Bowel Regimen for the Prevention of Opioid Induced Constipation in Trauma Patients","status":"TERMINATED","sponsor":"CAMC Health System","startDate":"2007-08","conditions":["Constipation","Analgesia"],"enrollment":3,"completionDate":"2012-10"},{"nctId":"NCT01773096","phase":"PHASE4","title":"Methylnaltrexone Use for Opioid-induced Postoperative Constipation","status":"COMPLETED","sponsor":"Shriners Hospitals for Children","startDate":"2013-05","conditions":["Constipation"],"enrollment":60,"completionDate":"2015-05"},{"nctId":"NCT02008864","phase":"NA","title":"Evaluating the Effect of Senna in Uremic Pruritus","status":"COMPLETED","sponsor":"Shiraz University of Medical Sciences","startDate":"2011-08","conditions":["End Stage Renal Disease","Pruritus"],"enrollment":60,"completionDate":""},{"nctId":"NCT00990951","phase":"PHASE3","title":"Study of Efficacy of Association of Senna Alexandrina Mill and Associations on Functional Intestinal Constipation","status":"SUSPENDED","sponsor":"Marjan Industria e Comercio ltda","startDate":"2010-06","conditions":["Constipation"],"enrollment":80,"completionDate":"2014-07"},{"nctId":"NCT01140295","phase":"PHASE4","title":"Bowel Preparation for Colonoscopy in Children","status":"TERMINATED","sponsor":"Children's Hospital of Philadelphia","startDate":"2010-09","conditions":["Colonoscopy Preparation"],"enrollment":33,"completionDate":"2011-05"},{"nctId":"NCT00994851","phase":"PHASE3","title":"Evaluation of Cassia Fistula + Senna Alexandrina Miller in the Chronic Functional Constipation Treatment.","status":"COMPLETED","sponsor":"Sanofi","startDate":"2009-09","conditions":["Constipation"],"enrollment":96,"completionDate":"2012-08"},{"nctId":"NCT00662363","phase":"NA","title":"Lubiprostone (Amitiza®) Vs. Standard Care in Opioid-induced Constipation After Surgery in Inpatient Rehabilitation","status":"COMPLETED","sponsor":"Shirley Ryan AbilityLab","startDate":"2008-04","conditions":["Constipation"],"enrollment":64,"completionDate":"2011-10"},{"nctId":"NCT00931853","phase":"PHASE3","title":"Efficacy and Tolerability of Cassia Fistula Plus Senna Alexandrina Miller (Sugar Free) in the Chronic Functional Constipation (CFC).","status":"COMPLETED","sponsor":"Sanofi","startDate":"2010-09","conditions":["Constipation"],"enrollment":117,"completionDate":"2011-12"},{"nctId":"NCT01531140","phase":"PHASE4","title":"PEG Versus PEG+Bisacodyl Versus Sennosides for Colon Cleansing Before Colonoscopy","status":"COMPLETED","sponsor":"Medical University of Warsaw","startDate":"2010-11","conditions":["Colonoscopy Preparation"],"enrollment":240,"completionDate":"2011-11"},{"nctId":"NCT00571896","phase":"PHASE2,PHASE3","title":"The Use of SennaS for Prevention of Post-operative Constipation After Urogynecologic Surgery","status":"COMPLETED","sponsor":"Hartford Hospital","startDate":"2008-01","conditions":["Constipation"],"enrollment":72,"completionDate":"2009-06"},{"nctId":"NCT00902031","phase":"NA","title":"Effectiveness of Docusate in Preventing/Treating Constipation in Palliative Care Patients","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2006-04","conditions":["Constipation","Palliative Care"],"enrollment":70,"completionDate":"2010-10"},{"nctId":"NCT00390598","phase":"PHASE2,PHASE3","title":"PEG Solution (Laxabon®) 4L Versus Senna Glycoside (Pursennid® Ex-Lax) 36mg and PEG Solution (Laxabon®) 2L for Large Bowel Cleansing Prior to Colonoscopy","status":"COMPLETED","sponsor":"Umeå University","startDate":"2005-09","conditions":["Colonoscopy"],"enrollment":490,"completionDate":"2006-12"},{"nctId":"NCT00460837","phase":"PHASE4","title":"Comparison of Bowel Preparation in Virtual Colonoscopy (VC) - Patient Experience","status":"WITHDRAWN","sponsor":"London North West Healthcare NHS Trust","startDate":"2007-11","conditions":["Colorectal Cancer"],"enrollment":150,"completionDate":"2009-03"},{"nctId":"NCT01057446","phase":"","title":"Comparison of Oral Sodium Phosphate and Sennoside A+B Calcium Lavage for Colonoscopy Preparation","status":"COMPLETED","sponsor":"Maltepe University","startDate":"","conditions":["Colonoscopy"],"enrollment":0,"completionDate":""},{"nctId":"NCT00275184","phase":"PHASE3","title":"Bowel Preparation and Prokinetics in Capsule Endoscopy","status":"UNKNOWN","sponsor":"London North West Healthcare NHS Trust","startDate":"2006-01","conditions":["Small Bowel Disease","Gastrointestinal Hemorrhage","Refractory Anemia"],"enrollment":150,"completionDate":""}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Oral","formulation":"Bar, Capsule, Extract, Liquid","formulations":[{"form":"BAR, CHEWABLE","route":"ORAL","productName":"Chocolated Laxative"},{"form":"CAPSULE","route":"ORAL","productName":"SENNA"},{"form":"CAPSULE","route":"ORAL","productName":"Super Colon Cleanse"},{"form":"CAPSULE, GELATIN COATED","route":"ORAL","productName":"SENNA"},{"form":"CAPSULE, GELATIN COATED","route":"ORAL","productName":"SENNA-S"},{"form":"CAPSULE, GELATIN COATED","route":"ORAL","productName":"STOOL SOFTENER"},{"form":"CAPSULE, GELATIN COATED","route":"ORAL","productName":"STOOL SOFTENER AND STIMULANT LAXATIVE"},{"form":"CAPSULE, GELATIN COATED","route":"ORAL","productName":"Senna Plus"},{"form":"CAPSULE, LIQUID FILLED","route":"ORAL","productName":"LAXATIVE"},{"form":"CAPSULE, LIQUID FILLED","route":"ORAL","productName":"SENNA"},{"form":"CAPSULE, LIQUID FILLED","route":"ORAL","productName":"Sennosides"},{"form":"EXTRACT","route":"ORAL","productName":"Bekunis Natures Gentle Laxative Herbal Tea"},{"form":"LIQUID","route":"ORAL","productName":"Little Remedies Little Tummys Laxative Drops"},{"form":"LIQUID","route":"ORAL","productName":"CVS Senna Laxative"},{"form":"LIQUID","route":"ORAL","productName":"GeriCare Senna Syrup"}]},"crossReferences":{"NUI":"N0000179238","MMSL":"5149","NDDF":"001169","UNII":"3FYP5M0IJX","VUID":"4021246","VANDF":"4019930","RXNORM":"36387","UMLSCUI":"C3489575","chemblId":"CHEMBL2108559","ChEMBL_ID":"CHEMBL2108559","DRUGBANK_ID":"DB11365","PUBCHEM_CID":"5199","SNOMEDCT_US":"30125007","SECONDARY_CAS_RN":"62211-03-4","MESH_DESCRIPTOR_UI":"D000081226"},"formularyStatus":[],"_enricherVersion":"v2","_offLabelChecked":true,"developmentCodes":[],"ownershipHistory":[],"publicationCount":250,"therapeuticAreas":["Gastroenterology"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"SENNOSIDES","companyName":"","companyId":"","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:08:36.299245+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}